There are no products listed under this category.
Welcome to CM Online Store!
Antibody Drug Conjugate (ADC) Kits!
AqT® bioconjugate Kits and Reagents!
Shop by Brand
Biotinylated Secondary Antibodies
AqT® Biotinylated Secondary Antibodies
CellMosaic’s AqT® biotinylated secondary antibodies are site-specifically labeled at reduced Fc-region disulfide bonds using our proprietary super-hydrophilic AqT® linker. Unlike conventional NHS ester chemistry, which randomly modifies surface lysine residues, this controlled labeling approach is designed to minimize disruption of antibody-binding activity while providing accessible biotin placement. With an average of 3–5 biotin molecules per antibody, these reagents provide strong streptavidin-mediated signal amplification for sensitive and reproducible immunodetection assays.
Why Use Biotinylated Secondary Antibodies?
Biotinylated secondary antibodies combine antibody-binding specificity with the exceptionally strong noncovalent interaction between biotin and streptavidin or avidin. After binding to a primary antibody, the biotinylated secondary antibody can be detected using streptavidin conjugated to an enzyme, fluorophore, nanoparticle, or other reporter. This detection system offers several advantages:
- High sensitivity: Multiple biotin molecules on each secondary antibody, together with labeled streptavidin, can provide substantial signal amplification.
- Detection flexibility: The same biotinylated antibody can be paired with streptavidin–HRP, streptavidin–alkaline phosphatase, fluorescent streptavidin, or other streptavidin conjugates.
- Simplified assay development: The detection method can be changed without replacing the primary or secondary antibody.
- Broad compatibility: Suitable for ELISA, Western blotting, immunohistochemistry, immunofluorescence, flow cytometry, and affinity-capture applications.
- Inventory efficiency: One biotinylated secondary antibody can support multiple assay formats and detection platforms.
- Strong and stable detection: The high-affinity biotin–streptavidin interaction provides stable binding under a wide range of assay conditions.
Why Labeling Quality Matters
The degree of labeling (DOL) must be carefully controlled. Insufficient biotinylation may produce weak signals, while excessive or poorly controlled labeling can reduce antibody activity, increase nonspecific binding, or promote aggregation. CellMosaic’s AqT® biotin technology and site-specific conjugation process are designed to:
- Maintain antibody solubility
- Reduce aggregation
- Preserve antibody-binding activity
- Provide a consistent biotin-to-antibody ratio
- Support reliable performance in sensitive immunoassays
Application Considerations
Endogenous biotin in certain tissues, cells, or biological samples may contribute to background signals. Appropriate avidin/biotin blocking procedures should be used when necessary. For samples with high endogenous biotin levels, a biotin-free detection system may be preferred.